SEI Investments’s Zentalis Pharmaceuticals ZNTL Stock Holding History

SEI Investments's ZNTL Position: Q2 2026 in Review

SEI Investments increased its Zentalis Pharmaceuticals (ZNTL) stake by 34% in Q2 2026, buying an estimated $258K and bringing the position to 256,079 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

SEI Investments first reported a position in ZNTL in Q2 2022 and has held it in 10 quarters since. The position peaked at $2.14M in Q2 2022. 114 funds tracked by Wall St. Rank hold ZNTL as of Q2 2026.

• SEI Investments held 256,079 shares of Zentalis Pharmaceuticals worth $1.24M as of Q2 2026.
• SEI Investments bought 64,528 Zentalis Pharmaceuticals shares in Q2 2026, an estimated $258K.
• Zentalis Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2194 holding.
• SEI Investments first reported a position in Zentalis Pharmaceuticals in Q2 2022 and has held it in 10 quarters since.
• SEI Investments's Zentalis Pharmaceuticals position peaked at $2.14M in Q2 2022.
• 114 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.